Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin

Journal of Pharmaceutical Sciences

Volumn 101, Issue 2, 2012, Pages 566-575

  Manca, Maria Letizia ^a   Manconi, Maria ^a   Valenti, Donatella ^a   Lai, Francesco ^a   Loy, Giuseppe ^a   Matricardi, Pietro ^b   Fadda, Anna Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aerosol; Biodegradable polymers; Chitosan; Hydrogels; Liposomes; Microparticles; Pulmonary drug delivery; Rheology; Rifampicin; Xanthan gum

Indexed keywords

CHITOSAN DERIVATIVE; CHITOSAN XANTHAN GUM; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYELECTROLYTE; RIFAMPICIN; UNCLASSIFIED DRUG; XANTHAN;

ARTICLE; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FLOW KINETICS; HYDROGENATION; IN VITRO STUDY; LIPID VESICLE; LIPOSOMAL DELIVERY; LUNG; MOLECULAR WEIGHT; MORPHOMETRICS; NEBULIZATION; NEBULIZER; PARTICLE SIZE; ZETA POTENTIAL;

EID: 84455169626     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22775     Document Type: Article

References (27)

1. Gilbert BE, Wyde PR, Wilson SZ, Robins RK. 1991. Aerosol and intraperitoneal administration of ribavarin and ribavarin triacetate: Pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrob Agents Chemother 35(7):1448-1453.
2. Barratt GM. 2003. Colloidal drug carriers: Achievements and perspectives. Cell Mol Life Sci 6:21-37.
3. Rytting E, Nguyen J, Wang X, Kissel T. 2008. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv 5:629-639.
4. Desai TR, Hancock REW, Finlay WH. 2002. A facile method of delivery of liposomes by nebulisation. J Control Release 84:69-78.
5. Zaru M, Mourtas S, Klepetsanis P, Fadda AM, Antimisiaris SG. 2007. Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67:655-666.
6. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. 2005. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59:57-62.
7. Santucci E, Carafa M, Coviello T, Murtas E, Riccieri FM, Alhaique F, Modesti A, Modica A. 1996. Vesicles from polysorbate 20 and cholesterol: A simple preparation and a characterization. STP Pharma Sciences 6:29-32.
8. Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. 2010. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts. J Control Release 147:127-135.
9. Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. 2004. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 269:37-49.
10. Xu Q, Tanaka Y, Czernuszka JT. 2007. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes. Biomaterials 28:2687-2694.
11. Coviello T, Matricardi P, Marianecci C, Alhaique F. 2007. Polysaccharide hydrogels for modified release formulations. J Control Release 119:5-24.
12. Grenha A, Al-Qadi S, Seijo B, Remuñán-López C. 2010. The potential of chitosan for pulmonary drug delivery. J Drug Del Sci Tech 20:33-43.
13. Henriksen I, Vagen SR, Sande SA, Smistad G, Karlsen J. 1997. Interactions between liposomes and chitosan II. Effect of selected parameters on aggregation and leakage. Int J Pharm 146:103-204.
14. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. 2003. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Rel 86:235-242.
15. Manconi M, Mura S, Manca ML, Fadda AM, Dolz M, Hernandez MJ, Casanova A, Diez-Sales O. 2010. Chitosomes as drug delivery systems for C-phycocianin: Preparation and characterization. Int J Pharm 392:92-100.
16. Zaru M, Manca ML, Fadda AM, Antimisiaris SG. 2009. Chitosan-coated liposomes for delivery to lungs by nebulization. Colloid Surface B 71:88-95.
17. Zaru M, Sinico C, De Logu A, Caddeo C, Lai F, Manca ML, Fadda AM. 2009. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: In vitro and in vivo evaluation. J Lip Res 19:68-76.
18. 31P-NMR and DSC study. Colloids Surfaces A: Physicochem Eng Aspects 158:59-66.
19. Corti G, Cirri M, Maestrelli F, Mennini N, Mura P. 2008. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. Eur J Pharm Biopharm 68:303-309.
20. Casadei MA, Matricardi P, Fabrizi G, Feeney M, Paolicelli P. 2007. Physical gels of a carboxymethyl derivative of scleroglucan: Synthesis and characterization. Eur J Pharm Biopharm 67:682-689.
21. Grassi M, Lapasin R, Coviello T, Matricardi P, Di Meo C, Alhaique F. 2009. Scleroglucan/borax/drug hydrogels: Structure characterisation by means of rheological and diffusion experiments. Carbohyd Polym 78:377-383.
22. Diez-Sales O, Dolz M, Hernandez MJ, Casanovas A, Herraez M. 2007. Rheological characterization of chitosan matrices: Influence of biopolymer concentration. J Appl Polym Sci 105:2121-2128.
23. Albasarah Y, Somavarapu S, Stapleton P, Taylor K. 2010. Chitosan-coated antifungal formulations for nebulisation. J Pharm Pharmacol 62:821-828.
24. Gaspar MM, Bakowsky U, Ehrhardt C. 2008. Inhaled liposomes-Current strategies and future challenges. J Biomed Nanotechnol 4:1-13.
25. Bridges PA, Taylor K. 2000. An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm 204:69-79.
26. Taylor KMG, Taylor G, Kellaway IW, Stevens J. 1990. The stability of liposomes to nebulisation. Int J Pharm 58:57-61.
27. Elhissi A, Gill H, Ahmed W, Taylor K. 2010. Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology. J Lip Res 21:173-180.